Post-effective amendment to a registration statement that is not immediately effective upon filing

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 02, 2021
Dec. 31, 2020
Dec. 31, 2019
OPERATING EXPENSES:                
Corporate, General and Administrative Expenses           $ 22,747,817    
OPERATING LOSS           (22,747,817)    
OTHER INCOME (EXPENSES):                
TOTAL OTHER INCOME (EXPENSE)           2,057,307    
NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS           $ (24,805,124)    
P3 Health Partners Inc.                
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor Successor Predecessor Predecessor Predecessor Predecessor
OPERATING REVENUE:                
TOTAL OPERATING REVENUE $ 58,762,397 $ 269,453,971 $ 144,586,444 $ 542,998,305 $ 295,884,386 $ 578,602,418 $ 491,063,525 $ 145,482,112
OPERATING EXPENSES:                
Medical Expenses 66,877,005 267,448,368 150,380,517 533,269,170 297,005,022 592,465,049 484,502,423 141,029,737
Premium Deficiency Reserve 26,276,575 (1,489,571) 1,000,000 (2,814,084) 3,000,000 11,559,067 (20,539,364) 6,363,652
Corporate, General and Administrative Expenses 16,983,132 41,098,400 18,390,659 79,697,812 33,449,735 100,243,148 53,390,338 36,423,532
Sales and Marketing Expenses 364,127 1,408,096 356,501 2,272,626 626,742 1,818,015 1,502,634 801,685
Amortization of Intangible Assets 6,961,666     42,285,014   34,396    
Depreciation 187,558 21,720,081 429,830 43,471,912 762,378 1,540,335 795,172 399,177
TOTAL OPERATING EXPENSES 117,650,063 1,181,641,128 170,557,507 1,507,353,190 334,843,877 707,660,010 519,651,203 185,017,783
OPERATING LOSS (58,887,666) (912,187,157) (25,971,063) (964,354,885) (38,959,491) (129,057,592) (28,587,678) (39,535,671)
OTHER INCOME (EXPENSES):                
Interest Expense, net (1,321,922) (2,733,875) (2,369,764) (5,495,125) (4,494,049) (9,677,477) (2,533,180) (2,533,842)
Mark-to-Market of Stock Warrants 2,271,659     5,953,817 (10,661,579) (7,664,869)    
Other             (290,684) 97,955
TOTAL OTHER INCOME (EXPENSE) 949,737 9,081,218 (3,493,347) 458,692 (15,155,628) (17,342,346) (2,823,864) (2,435,887)
LOSS BEFORE INCOME TAXES (57,937,929) (903,105,939) (29,464,410) (963,896,193) (54,115,119) (146,399,938) (31,411,542) (41,971,558)
PROVISION FOR INCOME TAXES 0     0 0 0 0 0
NET LOSS (57,937,929) (903,105,939) (29,464,410) (963,896,193) (54,115,119) (146,399,938) (31,411,542) (41,971,558)
LESS NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS (47,856,729) (748,755,990)   (798,968,740)        
NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS $ (10,081,200) $ (154,349,949) $ (29,464,410) $ (164,927,453) $ (54,115,119) (146,399,938) (31,411,542) (41,971,558)
NET LOSS PER SHARE (BASIC) $ (0.24) $ (3.71) [1] $ (3.97) [1]      
NET LOSS PER SHARE (DILUTED) $ (0.24) $ (3.73) [1] $ (4.01) [1]      
P3 Health Partners Inc. | Capitated Revenue                
OPERATING REVENUE:                
TOTAL OPERATING REVENUE $ 57,224,539 $ 267,102,466 $ 141,560,867 $ 536,787,281 $ 290,525,057 567,735,297 480,739,577 139,332,707
P3 Health Partners Inc. | Other Patient Service Revenue                
OPERATING REVENUE:                
TOTAL OPERATING REVENUE $ 1,537,858 $ 2,351,505 $ 3,025,577 $ 6,211,024 $ 5,359,329 $ 10,867,121 $ 10,323,948 $ 6,149,405
[1] ) The Company analyzed the calculation of net loss per member unit for predecessor periods prior to the Business Combinations and determined that it resulted in values that would not be meaningful to the users of these consolidated financial statements. Therefore, net loss per member unit information has not been presented for predecessor periods prior to the Business Combinations on December 3, 2021.